Page last updated: 2024-10-26

dipyridamole and Pericarditis

dipyridamole has been researched along with Pericarditis in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Pericarditis: Inflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Vita, C1
Utting, JA1
Shreeve, DR1

Other Studies

2 other studies available for dipyridamole and Pericarditis

ArticleYear
[Problems of the operated patient and suggestions for their treatment].
    Giornale italiano di cardiologia, 1982, Volume: 12, Issue:3

    Topics: Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Anxiety Disorders; Arrhythmias, Cardiac; As

1982
Haemolytic-uraemic syndrome in an adult with pericarditis and pleurisy.
    British medical journal, 1973, Jun-09, Volume: 2, Issue:5866

    Topics: Adult; Alopecia; Anemia, Hemolytic; Aspirin; Dipyridamole; Female; Hemolytic-Uremic Syndrome; Hepari

1973